Laurus Labs Ltd. (LAURUSLABS): Laurus Labs Share Price Rises 3.47% Today as Large Cap Stock Enters Top Gainers

Laurus Labs Ltd. traded at Rs 1,858.50, up 3.47% today, taking its market capitalisation to Rs 98,047.76 crore and placing the stock among the session’s notable gainers.

Laurus Labs Share Price moved higher to Rs 1,858.50 on 25 August 2026, rising 3.47% from the previous close of Rs 1,796.25 and adding Rs 62.25 in a single session. With a market capitalisation of Rs 98,047.76 crore, Laurus Labs Ltd. is clearly positioned in the Large Cap category, and the move was significant enough to qualify under the workflow’s price rise screen. For readers tracking Laurus Labs Share Price Today and Laurus Labs Stock News, the core fact is straightforward: the stock was among the market’s top gainers in today’s trade based on verified price data.

The session also showed firm intraday strength. The stock opened at Rs 1,809.60, stayed above the day’s low of Rs 1,799.00, and climbed to an intraday high of Rs 1,858.50, which was also the current traded price at the time of the trigger. That pattern matters because it shows gains were not limited to a brief opening spike. Instead, the price action held up through the session and kept Laurus Labs Share Price in focus across Stock Market Today searches.

The supplied data confirms the price event, trading activity and market-cap context, but it does not establish a company-specific catalyst for why Laurus Labs is rising today. Even so, the move is relevant because it combines a clear share price gain with active participation across exchanges. As Univest tracks Laurus Labs Share Price, the next logical step is to examine the session’s price action, then place the move in sector and peer context.

Laurus Labs Ltd. (LAURUSLABS) Share Price Today: Price Action Analysis

Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,858.5. versus the previous close of Rs 1,796.25, a rise of 3.47%. The stock opened at Rs 1,809.6, reached Rs 1,858.5, touched Rs 1,799. Reported volume was 46,540.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Laurus Labs Share Price is attracting attention primarily through market action today, but the company’s size alone gives the move added importance. At a market capitalisation of Rs 98,047.76 crore, Laurus Labs Ltd. sits on a completely different scale from the median company in the supplied Healthcare benchmark set. Market capitalisation is not a judgment on quality, yet it does show that today’s price rise is happening in a stock that is already substantial in absolute size.

That context becomes clearer when placed against the benchmark statistics. In the same-sector Healthcare universe, the benchmark covers 195 companies. The median market capitalisation is Rs 140.36 crore and the average is Rs 477.14 crore, with the range running from Rs 3.32 crore to Rs 2,970.30 crore in the supplied benchmark set. Against those figures, Laurus Labs Share Price Today is attached to a company whose market cap of Rs 98,047.76 crore is far larger than both the benchmark median and average. In other words, today’s share price gain is not occurring in a niche micro-sized counter but in a very large listed Healthcare name.

The absence of company-specific valuation ratios in the supplied workflow means the cleanest fundamental context here is scale, classification and comparative sector positioning. For investors reading Laurus Labs Fundamental Analysis and Laurus Labs Market Cap trends, that still matters. A 3.47% price rise in a company of this size can naturally draw wider market attention than a similar percentage move in a much smaller stock.

That is also why Univest treats the event as more than a one-line market update. Laurus Labs Share Price has recorded a qualifying move inside the Large Cap category, and its large absolute market value means the stock’s movement often carries screening relevance for broader Healthcare watchlists. The next layer of analysis, therefore, is less about unsupported speculation and more about comparing the stock’s market standing with its sector snapshot and peer group.

Sector and Industry Context

Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The Healthcare sector snapshot shows a wide spread in valuations and profitability across the listed universe. Laurus Labs Share Price is therefore moving inside a sector where market-cap dispersion, valuation ranges and return ratios differ sharply across companies, making context especially important.

The supplied sector name is Healthcare, and the benchmark scope is explicitly described as the same sector, covering 195 companies. On valuation, the benchmark P/E data spans 157 companies, with a median of 25.78, an average of 61.44, a minimum of 2.94 and a maximum of 1,608.25. That wide range suggests the Healthcare basket includes both modestly valued and very richly valued companies, so sector averages alone should be read with caution. For Laurus Labs Share Price News, this is relevant because sector-wide comparisons in Healthcare can vary sharply depending on business model and profitability profile.

The benchmark P/B statistics show a similarly broad spread. Across 194 companies, the median P/B is 2.00 and the average is 2.71, while the range stretches from -11.99 to 16.88. On profitability, the sector median ROE is 11.09% and the average is 15.72% across 194 companies. ROCE is slightly stronger at the median level, with 13.57% as the median and 17.97% as the average, again across 194 companies.

The market-cap distribution in the same sector is equally striking. The median market capitalisation is Rs 140.36 crore and the average is Rs 477.14 crore, with the supplied range running from Rs 3.32 crore to Rs 2,970.30 crore. Against that benchmark set, Laurus Labs Share Price is tied to a company with a market capitalisation of Rs 98,047.76 crore, making it an outlier in size versus the supplied Healthcare benchmark sample. That scale difference alone helps explain why a 3.47% move in Laurus Labs becomes visible in Stocks in News, Top Gainers Today and broader Market News tracking. Univest readers should read today’s move not in isolation, but as price action in a very large Healthcare stock operating inside a highly varied sector universe.

Peer Comparison

Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 98,047.76 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peer set shows Laurus Labs sitting against much smaller listed Healthcare names, mostly in Pharmaceuticals & Drugs, with one Hospital & Healthcare Services company also included. Even without company-specific Laurus valuation multiples in the workflow, the peer numbers still help frame where this stock sits in terms of market presence.

On market capitalisation, the contrast is immediate. Laurus Labs stands at Rs 98,047.76 crore. The supplied peers range from Rs 2,313.02 crore for Venus Remedies Ltd. to Rs 2,970.30 crore for Solara Active Pharma Sciences Ltd. Ind-Swift Laboratories Ltd. is at Rs 2,864.08 crore, Dishman Carbogen Amcis Ltd. at Rs 2,725.67 crore, Hikal Ltd. at Rs 2,667.00 crore, Dr Agarwals Eye Hospital Ltd. at Rs 2,594.96 crore, Beta Drugs Ltd. at Rs 2,588.69 crore, Panacea Biotec Ltd. at Rs 2,513.73 crore, Sai Parenteral’s Ltd. at Rs 2,391.86 crore and Fredun Pharmaceuticals Ltd. at Rs 2,373.46 crore. By scale, Laurus Labs is many times larger than every peer listed in the supplied dataset.

The peer valuation and return profile is mixed. Among companies with P/E data, Venus Remedies trades at 19.59, Dr Agarwals Eye Hospital at 34.05, Ind-Swift Laboratories at 49.64, Fredun Pharmaceuticals at 53.93, Beta Drugs at 61.85, Sai Parenteral’s at 141.70 and Dishman Carbogen Amcis at 167.99. P/B values also vary materially, from 0.41 for Dishman Carbogen Amcis to 9.78 for Beta Drugs. ROE ranges from -2.89% for Dishman Carbogen Amcis and -0.78% for Ind-Swift Laboratories to 36.29% for Dr Agarwals Eye Hospital. ROCE ranges from -0.26% for Dishman Carbogen Amcis to 42.40% for Dr Agarwals Eye Hospital.

That spread matters for Laurus Labs Stock Analysis because it shows just how diverse Healthcare peer sets can be even within a narrow market-cap band. The peer table inserted by the workflow will carry the exact comparisons, while the main editorial takeaway is simple: Laurus Labs Share Price is moving today in a company whose market scale stands well above the supplied peer group, while the surrounding sector still shows wide variation in valuation and profitability metrics.

Why Investors Are Watching Laurus Labs

Laurus Labs Share Price is in focus because today’s move combines a clear gain, strong intraday positioning and large-cap relevance. For investors following Laurus Labs Share Price Today, the stock has delivered a measurable share price rise rather than a marginal fluctuation, and it has done so in a sizeable Healthcare name that naturally attracts screen-based attention across the market.

• Verified price action: the stock rose Rs 62.25, or 3.47%, from Rs 1,796.25 to Rs 1,858.50.
• Intraday position: the current price matched the day’s high of Rs 1,858.50 after opening at Rs 1,809.60 and touching a low of Rs 1,799.00.
• Trading activity: total volume reached 26,22,198 shares, including 46,540 on BSE and 25,75,658 on NSE, with turnover at Rs 8.65 crore.
• Market-cap context: Laurus Labs carries a market capitalisation of Rs 98,047.76 crore and is classified as Large Cap.
• Sector positioning: the Healthcare benchmark covers 195 companies, yet the supplied market-cap averages are far below Laurus Labs.

For Univest users, the next thing to monitor is whether Laurus Labs Share Price continues to hold near the upper end of its intraday range and whether the stock remains prominent in top-gainer screens. The data already confirms a meaningful one-day move; what investors typically watch next is whether attention remains broad-based across market sessions and sector comparisons.

About Laurus Labs

Laurus Labs Ltd. is identified in the supplied market dataset as part of the Healthcare sector. The peer and benchmark group around it is largely concentrated in Pharmaceuticals & Drugs, with one Hospital & Healthcare Services name also appearing in the comparison set. That places Laurus Labs Share Price within one of the Indian market’s most closely tracked sectors, where valuation, profitability and market-cap dispersion can be unusually wide.

From a market-structure perspective, Laurus Labs is not being discussed here as a small specialised counter. Instead, it stands out because its market capitalisation of Rs 98,047.76 crore is much larger than the market-cap figures shown for the supplied Healthcare peer set and benchmark sample. That difference means Laurus Labs Share Price often attracts a different class of market attention than smaller pharmaceutical and healthcare companies, especially on days when it enters top-gainer filters.

The broader Healthcare benchmark in the supplied data covers 195 same-sector companies and shows large spreads in P/E, P/B, ROE and ROCE. That tells readers something important about the ecosystem in which Laurus Labs trades: sector comparisons are useful, but they need to be read with care because the group contains companies with very different business profiles, valuations and return characteristics. For Univest readers following Laurus Labs Share News and Laurus Labs Latest News, the company’s immediate relevance today comes from this combination of scale, sector visibility and a verified price rise.

Track Laurus Labs Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors who follow Laurus Labs Share Price can use Univest to keep track of live market moves, day-by-day share price changes and deeper stock context in one place. Alongside Laurus Labs Share Price Today, users can monitor market capitalisation, 52-week levels, sector placement, peer comparisons and broader market insights that help explain how a stock is trading relative to its industry basket.

Univest is especially useful when a stock appears in top-gainer screens, because readers often want more than a headline move. They want to see how the day’s price compares with the previous close, where the stock traded intraday, and how its scale stacks up against sector and peer benchmarks. That is exactly the kind of context Univest aims to organise clearly for ongoing stock tracking.

Frequently Asked Questions

Why is Laurus Labs Share Price rising today?

Ans. Laurus Labs Share Price rose because the stock recorded a verified 3.47% single-day gain, moving from Rs 1,796.25 to Rs 1,858.50. The supplied data confirms the price rise and active trading, but it does not identify a company-specific catalyst.

What is Laurus Labs Share Price Today?

Ans. Laurus Labs Share Price Today was Rs 1,858.50 at the time of the event capture. That was also the day's high, after the stock opened at Rs 1,809.60 and traded within an intraday range of Rs 1,799.00 to Rs 1,858.50.

How much did Laurus Labs stock gain today?

Ans. Laurus Labs stock gained Rs 62.25 in today's session, which translates into a 3.47% rise over the previous close of Rs 1,796.25. That move was sufficient to place the stock in the workflow's Large Cap price-rise event screen.

What was the opening price of Laurus Labs today?

Ans. Laurus Labs opened at Rs 1,809.60 today. The stock then touched a low of Rs 1,799.00 before moving higher and reaching Rs 1,858.50, showing that the session's strongest level was sustained into the captured market update.

What was the intraday high and low for Laurus Labs?

Ans. The intraday low for Laurus Labs was Rs 1,799.00 and the intraday high was Rs 1,858.50. Because the current price matched the high, the trading pattern suggested strength through the session rather than a brief opening-only rise.

What was the total trading volume in Laurus Labs today?

Ans. Total traded volume in Laurus Labs was 26,22,198 shares. Of this, 46,540 shares were reported on BSE and 25,75,658 shares on NSE, showing that exchange participation was heavily concentrated in NSE during the session.

What is the market capitalisation of Laurus Labs?

Ans. Laurus Labs had a market capitalisation of Rs 98,047.76 crore in the supplied market update. That places it in the Large Cap category and makes today's 3.47% move notable because it came in a stock with substantial market size.

Which sector does Laurus Labs belong to?

Ans. Laurus Labs belongs to the Healthcare sector in the supplied dataset. The same-sector benchmark covers 195 companies, with wide spreads in valuation and profitability metrics, which is why sector context matters when reading Laurus Labs Share Price News.

How does Laurus Labs compare with the supplied peer group in size?

Ans. Laurus Labs is much larger than every company in the supplied peer set on market capitalisation. Laurus Labs stands at Rs 98,047.76 crore, while the listed peers range from Rs 2,313.02 crore to Rs 2,970.30 crore.

Why is Laurus Labs trending in market screens today?

Ans. Laurus Labs is trending because the stock delivered a verified price rise of 3.47%, traded 26,22,198 shares in total, and held at the day's high of Rs 1,858.50. That combination naturally places it among closely watched top gainers today.